Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,094 public trials 2,044 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia

NCT00495079

Conditions
Acute Lymphoblastic Leukemia (ALL), Disease Attributes, Hematologic Diseases, +13 more
Locations
  • USC - Norris Cancer Center Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of California Medical Center San Francisco, California, United States
  • Stanford Hospitals and Clinics Stanford, California, United States
View all 33 locations
View Trial Details
Completed

Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia

NCT02165397

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford Cancer Center Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Emory University Hospital Atlanta, Georgia, United States
View all 48 locations
View Trial Details
Completed

Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)

NCT02939014

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Sun Yat-san University Cancer Center Guangzhou, Guangdong, China
  • Jiangsu Cancer Hospital Nanjing, Jiangsu, China
View Trial Details

Related conditions